Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 09 11:27AM ET
179.49
Dollar change
+3.03
Percentage change
1.72
%
IndexS&P 500 P/E33.75 EPS (ttm)5.32 Insider Own0.08% Shs Outstand451.55M Perf Week1.51%
Market Cap81.76B Forward P/E28.14 EPS next Y6.38 Insider Trans-0.95% Shs Float450.80M Perf Month3.01%
Income2.43B PEG3.63 EPS next Q1.38 Inst Own94.82% Short Float1.04% Perf Quarter-6.20%
Sales9.15B P/S8.93 EPS this Y10.75% Inst Trans-1.48% Short Ratio2.10 Perf Half Y0.37%
Book/sh11.59 P/B15.48 EPS next Y8.26% ROA17.07% Short Interest4.69M Perf Year-1.29%
Cash/sh3.76 P/C47.70 EPS next 5Y9.29% ROE47.13% 52W Range144.80 - 201.92 Perf YTD-9.06%
Dividend Est.1.70 (0.95%) P/FCF35.43 EPS past 5Y11.57% ROI20.27% 52W High-11.11% Beta0.88
Dividend TTM1.73 (0.96%) Quick Ratio2.27 Sales past 5Y8.05% Gross Margin68.49% 52W Low23.96% ATR (14)3.82
Dividend Ex-DateOct 31, 2024 Current Ratio3.69 EPS Y/Y TTM8.09% Oper. Margin36.45% RSI (14)53.56 Volatility2.05% 2.07%
Employees14100 Debt/Eq1.29 Sales Y/Y TTM9.33% Profit Margin26.55% Recom1.43 Target Price220.60
Option/ShortYes / Yes LT Debt/Eq1.29 EPS Q/Q16.43% Payout30.71% Rel Volume1.28 Prev Close176.46
Sales Surprise4.34% EPS Surprise8.49% Sales Q/Q11.02% EarningsNov 04 BMO Avg Volume2.23M Price179.49
SMA201.85% SMA50-1.44% SMA2001.11% Trades Volume954,858 Change1.72%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Initiated Leerink Partners Outperform $215
Jul-25-24Initiated BTIG Research Buy $220
Jan-12-24Reiterated Stifel Buy $195 → $215
Dec-19-23Resumed Jefferies Buy $230
Dec-07-23Initiated Exane BNP Paribas Outperform $237
Sep-06-23Initiated HSBC Securities Buy $230
Jul-12-22Initiated Piper Sandler Overweight $205
Nov-18-21Initiated Morgan Stanley Overweight $40
Nov-18-21Initiated Morgan Stanley Overweight $264
Aug-05-21Resumed Credit Suisse Outperform $206
Dec-04-24 11:30AM
Nov-30-24 04:20PM
Nov-27-24 09:45AM
Nov-25-24 03:03PM
08:45AM
08:30AM Loading…
Nov-19-24 08:30AM
Nov-13-24 07:35PM
Nov-11-24 09:45AM
09:20AM
Nov-08-24 05:40AM
02:16AM
Nov-07-24 08:41AM
08:30AM
Nov-05-24 02:04AM
12:02AM
11:55PM Loading…
Nov-04-24 11:55PM
04:06PM
01:17PM
12:30PM
10:22AM
09:30AM
09:05AM
08:10AM
07:58AM
07:06AM
07:00AM
Oct-31-24 04:10PM
Oct-30-24 09:15AM
Oct-28-24 06:15PM
10:01AM
06:23PM Loading…
Oct-24-24 06:23PM
Oct-21-24 12:10PM
Oct-10-24 04:23PM
Oct-09-24 06:43PM
Sep-28-24 09:58PM
Sep-26-24 09:00AM
Sep-19-24 08:30AM
Sep-16-24 06:20PM
Sep-13-24 06:15PM
Sep-06-24 07:31AM
Sep-05-24 11:31AM
Aug-26-24 12:15PM
Aug-20-24 08:30AM
Aug-19-24 12:39PM
Aug-07-24 03:34PM
09:35AM
09:30AM
09:30AM
02:04AM
01:01AM
Aug-06-24 06:04PM
05:01PM
04:26PM
04:24PM
04:01PM
04:00PM
01:06PM
01:00PM
11:45AM
11:33AM
10:43AM
08:10AM
07:43AM
07:07AM
07:00AM
Aug-01-24 06:15PM
04:30PM
09:15AM
Jul-31-24 10:14AM
07:26AM
Jul-30-24 10:01AM
08:30AM
Jul-29-24 04:42PM
Jul-28-24 03:40AM
Jul-26-24 06:15PM
Jul-12-24 08:00AM
Jul-08-24 04:45PM
Jul-02-24 08:30AM
Jun-28-24 08:25PM
Jun-26-24 02:11PM
08:00AM
Jun-20-24 11:02AM
09:25AM
Jun-15-24 08:46AM
Jun-11-24 01:02PM
Jun-05-24 09:00AM
07:30AM
May-31-24 12:01AM
May-30-24 08:15AM
May-29-24 12:53PM
May-27-24 02:01AM
May-23-24 09:04PM
May-22-24 04:30PM
May-21-24 08:30AM
May-19-24 10:55AM
May-16-24 12:43PM
08:30AM
May-14-24 01:00PM
May-13-24 02:25PM
May-11-24 08:43AM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Polzer Robert JExecutive Vice PresidentNov 25 '24Option Exercise161.633,477561,9856,726Nov 26 04:27 PM
Polzer Robert JExecutive Vice PresidentNov 25 '24Sale177.463,477617,0283,249Nov 26 04:27 PM
Polzer Robert JOfficerNov 25 '24Proposed Sale177.463,477617,029Nov 25 04:20 PM
Lagano RoxanneExecutive Vice PresidentApr 18 '24Sale151.17923139,53014,800Apr 18 04:37 PM
Lagano RoxanneExecutive Vice PresidentMar 18 '24Sale173.33923159,98415,723Mar 18 04:33 PM
Reed Willie MDirectorMar 11 '24Sale182.681,370250,2659,994Mar 12 04:19 PM
PECK KRISTIN CChief Executive OfficerFeb 20 '24Option Exercise46.0913,000599,17092,366Feb 21 04:39 PM
PECK KRISTIN CChief Executive OfficerFeb 20 '24Sale187.2013,0002,433,63679,366Feb 21 04:39 PM
Lagano RoxanneExecutive Vice PresidentFeb 20 '24Sale187.30923172,87816,646Feb 21 04:38 PM
Lagano RoxanneExecutive Vice PresidentFeb 13 '24Sale186.862,848532,17717,569Feb 14 05:04 PM
Lagano RoxanneExecutive Vice PresidentFeb 12 '24Sale197.7436371,78020,417Feb 14 05:04 PM
Lagano RoxanneExecutive Vice PresidentJan 18 '24Sale191.43923176,69017,569Jan 19 05:07 PM
Lagano RoxanneExecutive Vice PresidentDec 18 '23Sale198.14923182,88318,492Dec 19 04:33 PM
Lagano RoxanneExecutive Vice PresidentDec 14 '23Sale200.002,500500,00019,415Dec 14 04:55 PM